Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (181-190 of 655) with videos related to

Pageof 66
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Chemotherapy administration and data collection in an EORTC collaborative group--can we trust the results?W P Steward, K Vantongelen, J Verweij, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1987
Relationship between clinical parameters and pharmacokinetics of mitomycin CJ Verweij, J den Hartigh, M Stuurman, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam Cooperative Head and Neck Cancer Study GroupJ Verweij, J Alexieva-Figusch, M F de Boer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 1, 1992
Phase I study of intravenous fosquidone (GR63178A-NSC D611615) using a three times a week scheduleA S Planting, M E van der Burg, G Stoter, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 21, 1997
Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detectionP de Bruijn, J Verweij, W J Loos, et al.
British Journal of Cancer|January 1, 1997
Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical developmentC J Gerrits, M J de Jonge, J H Schellens, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 14, 1998
Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detectionA Sparreboom, P de Bruijn, K Nooter, et al.
Clinical Pharmacology and Therapeutics|May 26, 1999
Clinical pharmacokinetics of encapsulated oral 9-aminocamptothecin in plasma and salivaM J de Jonge, J Verweij, W J Loos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Phase I pharmacokinetic and sequence finding study of the combination of docetaxel and methotrexate in patients with solid tumoursM Louwerens, C Smorenburg, A Sparreboom, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 8, 2022
SARS-CoV-2 transmitters have more than three times higher viral loads than non-transmitters - Practical use of viral load for disease controlR Jajou, Ajg Mutsaers-van Oudheusden, J J Verweij, et al.
Pageof 66

Showing results (181-190 of 655) with videos related to

Sort By:
Pageof 66
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Chemotherapy administration and data collection in an EORTC collaborative group--can we trust the results?W P Steward, K Vantongelen, J Verweij, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1987
Relationship between clinical parameters and pharmacokinetics of mitomycin CJ Verweij, J den Hartigh, M Stuurman, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1988
Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam Cooperative Head and Neck Cancer Study GroupJ Verweij, J Alexieva-Figusch, M F de Boer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 1, 1992
Phase I study of intravenous fosquidone (GR63178A-NSC D611615) using a three times a week scheduleA S Planting, M E van der Burg, G Stoter, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 21, 1997
Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detectionP de Bruijn, J Verweij, W J Loos, et al.
British Journal of Cancer|January 1, 1997
Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical developmentC J Gerrits, M J de Jonge, J H Schellens, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 14, 1998
Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detectionA Sparreboom, P de Bruijn, K Nooter, et al.
Clinical Pharmacology and Therapeutics|May 26, 1999
Clinical pharmacokinetics of encapsulated oral 9-aminocamptothecin in plasma and salivaM J de Jonge, J Verweij, W J Loos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Phase I pharmacokinetic and sequence finding study of the combination of docetaxel and methotrexate in patients with solid tumoursM Louwerens, C Smorenburg, A Sparreboom, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 8, 2022
SARS-CoV-2 transmitters have more than three times higher viral loads than non-transmitters - Practical use of viral load for disease controlR Jajou, Ajg Mutsaers-van Oudheusden, J J Verweij, et al.
Pageof 66